The design and synthesis of novel SGLT2 inhibitors: C-glycosides with benzyltriazolopyridinone and phenylhydantoin as the aglycone moieties
- 1 July 2014
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 22 (13) , 3414-3422
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 DiabetesJournal of Medicinal Chemistry, 2008
- A novel missense mutation in SLC5A2 encoding SGLT2 underlies autosomal-recessive renal glucosuria and aminoaciduriaKidney International, 2005
- A novel SGLT2 mutation in a patient with autosomal recessive renal glucosuriaNephrology Dialysis Transplantation, 2004
- Renal glucosuria due to SGLT2 mutationsMolecular Genetics and Metabolism, 2004
- Molecular Analysis of the SGLT2 Gene in Patients with Renal GlucosuriaJournal of the American Society of Nephrology, 2003
- Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2)Human Genetics, 2002
- In vivo regulation of the β-myosin heavy chain gene in hypertensive rodent heartAmerican Journal of Physiology-Cell Physiology, 2001
- Missense mutations in SGLT1 cause glucose–galactose malabsorption by trafficking defectsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1999
- Biophysical Characteristics of the Pig Kidney Na+/Glucose Cotransporter SGLT2 Reveal a Common Mechanism for SGLT1 and SGLT2Journal of Biological Chemistry, 1996
- The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose.Journal of Clinical Investigation, 1994